Chromadex Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1710774076
USD
4.66
-0.11 (-2.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
129.42
99.60
83.57
72.05
67.45
59.26
46.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
129.42
99.60
83.57
72.05
67.45
59.26
46.29
Raw Material Cost
46.23
38.01
32.79
29.25
25.96
23.98
20.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.06
0.07
0.85
Selling and Distribution Expenses
62.56
47.84
47.72
46.70
48.33
42.80
41.22
Other Expenses
0.63
0.60
0.50
0.48
0.38
0.37
0.36
Total Expenditure (Excl Depreciation)
115.13
91.87
85.47
80.78
78.12
70.51
66.17
Operating Profit (PBDIT) excl Other Income
14.299999999999999
7.7
-1.9
-8.7
-10.700000000000001
-11.299999999999999
-19.9
Other Income
3.90
1.13
0.66
2.09
0.00
0.00
0.00
Operating Profit (PBDIT)
19.64
10.34
0.47
-4.76
-9.05
-9.74
-18.48
Interest
0.00
0.00
0.00
0.00
0.06
0.07
0.85
Exceptional Items
0.00
0.00
-3.70
-9.90
-16.40
-8.60
-11.30
Gross Profit (PBDT)
83.19
61.59
50.78
42.80
41.49
35.27
25.77
Depreciation
1.45
1.48
1.71
1.88
1.63
1.51
1.52
Profit Before Tax
18.19
8.86
-4.94
-16.54
-27.13
-19.93
-32.15
Tax
0.81
0.30
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.38
8.55
-4.94
-16.54
-27.13
-19.93
-32.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.38
8.55
-4.94
-16.54
-27.13
-19.93
-32.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.38
8.55
-4.94
-16.54
-27.13
-19.93
-32.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
76.53
46.09
28.46
28.67
31.73
16.42
20.45
Earnings per share (EPS)
0.2
0.11
-0.07
-0.24
-0.4
-0.33
-0.56
Diluted Earnings per share
0.2
0.11
-0.07
-0.24
-0.4
-0.33
-0.56
Operating Profit Margin (Excl OI)
11.05%
7.76%
-2.27%
-12.11%
-15.82%
-18.99%
-43.2%
Gross Profit Margin
15.18%
10.38%
-3.87%
-20.34%
-37.81%
-31.07%
-66.16%
PAT Margin
13.43%
8.58%
-5.91%
-22.96%
-40.22%
-33.62%
-69.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 29.92% vs 19.14% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 102.33% vs 275.51% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 70.65% vs 4,700.00% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Chromadex Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
129.42
480.14
-350.72
-73.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
129.42
480.14
-350.72
-73.05%
Raw Material Cost
46.23
146.26
-100.03
-68.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.10
-0.10
-100.00%
Selling and Distribution Expenses
62.56
307.24
-244.68
-79.64%
Other Expenses
0.63
0.18
0.45
250.00%
Total Expenditure (Excl Depreciation)
115.13
455.40
-340.27
-74.72%
Operating Profit (PBDIT) excl Other Income
14.30
24.74
-10.44
-42.20%
Other Income
3.90
5.17
-1.27
-24.56%
Operating Profit (PBDIT)
19.64
43.75
-24.11
-55.11%
Interest
0.00
0.10
-0.10
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
83.19
333.88
-250.69
-75.08%
Depreciation
1.45
13.84
-12.39
-89.52%
Profit Before Tax
18.19
29.81
-11.62
-38.98%
Tax
0.81
9.36
-8.55
-91.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
17.38
19.52
-2.14
-10.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.38
19.52
-2.14
-10.96%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.93
-0.93
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.38
20.45
-3.07
-15.01%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
76.53
161.55
-85.02
-52.63%
Earnings per share (EPS)
0.20
1.06
-0.86
-81.13%
Diluted Earnings per share
0.20
1.06
-0.86
-81.13%
Operating Profit Margin (Excl OI)
11.05%
5.15%
0.00
5.90%
Gross Profit Margin
15.18%
9.09%
0.00
6.09%
PAT Margin
13.43%
4.07%
0.00
9.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 12.94 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 29.92% vs 19.14% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 1.74 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 102.33% vs 275.51% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.57 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 70.65% vs 4,700.00% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.05%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024